Unblinded Data Collection Study of Concussion Using BrainPulse
18 de septiembre de 2018 actualizado por: Jan Medical, Inc.
A Study to Assess the Effectiveness of the BrainPulse as an Aid to the Diagnosis of Concussion
This is a prospective, non-blinded, matched control study of young athletes (ages 10-28 years old) in collegiate sports.
The cohorts are defined in accordance to the athlete's exposure of injury.
All subjects will complete a minimum of one recording based on their assigned cohort.
Concussed athletes will complete an additional 3 weeks of follow-up recordings post injury.
The symptomatic evaluation, physical examination, neurological baseline testing, and BrainPulse recordings will be entered in a database to determine clinical outcome and assess device utilization.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
Cohort I is defined as all enrolled athletes at the University of Wyoming and is divided into two sub-cohorts: Cohort Ia include all athletes participating in Division 1 Athletics; Cohort Ib are athletes subscribed to the Head Health Network.
Cohort II is defined as all injured athletes participating in the teams and includes two sub-cohorts: Cohort IIa is defined as non- concussed injured athletes; Cohort IIb concussed athletes per reference standard.
Tipo de estudio
De observación
Inscripción (Actual)
353
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Wyoming
-
Laramie, Wyoming, Estados Unidos, 82070
- University of Wyoming
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años a 28 años (Adulto)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Todos
Método de muestreo
Muestra no probabilística
Población de estudio
Athletes participating in Division 1 Athletics at the University of Wyoming
Descripción
Inclusion Criteria:
- Male or female young athletes between ages 18-28 yrs
- Enrolled at the University of Wyoming and currently participating in Division 1 Athletics
- Completed the following baseline testing: SWAY balance, King-Devick, C3-Logix
- Willing and able to participate in all study evaluations and allow access to medical testing and records
- Signed informed consent, or have a legally authorized representative willing to provide informed consent on behalf of the subject if the subject is a minor
Exclusion Criteria:
- Prior concussion diagnosed by a physician in the last 2 weeks assessed via interview with athlete (not including a recent concussion within the last 3 days)
- Any serious medical, social or psychological condition that in the opinion of the investigator would impair ability to provide informed consent or otherwise disqualify a patient from participation
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Cohort Ia
Athletes in this cohort serve as control subjects participating in Division 1 Athletics at the University of Wyoming.
They will be enrolled once they meet eligibility.
Upon enrollment, all athletes will have an initial BrainPulse recording.
Once a subject from this cohort sustains an injury, they crossover to Cohort II.
Also, a matched control for every concussed subject will be selected from Cohort Ia.
|
JanMedical's BrainPulse measures the brain motion caused by pulsatile blood flow from the cardiac cycle referred to as the BrainPulse signal.
The BrainPulse measures skull acceleration in response to tge brain motion using an array of sensors placed on the head.
|
|
Cohort Ib
Athletes in this cohort are subjects currently subscribed to the Head Health Network.
They will have a BrainPulse recording completed every week through the entire season.
Similarly, if subjects in this cohort sustain an injury, they will crossover to Cohort II.
|
JanMedical's BrainPulse measures the brain motion caused by pulsatile blood flow from the cardiac cycle referred to as the BrainPulse signal.
The BrainPulse measures skull acceleration in response to tge brain motion using an array of sensors placed on the head.
|
|
Cohort IIa
Athletes from Cohort I will be assigned to cohort IIa once they sustain an injury other than concussion.
They will have been pulled out of the game by the athletic trainer and removed from play until at least the end of the game.
Once the subjects have been assigned to Cohort IIa, they will have a BrainPulse recording and a symptom evaluation within 3 days of their injury.
After two weeks of recovery, subjects in this cohort will return to Cohort 1 and resume their participation in the study in their respective sub-cohort.
|
JanMedical's BrainPulse measures the brain motion caused by pulsatile blood flow from the cardiac cycle referred to as the BrainPulse signal.
The BrainPulse measures skull acceleration in response to tge brain motion using an array of sensors placed on the head.
|
|
Cohort IIb
Athletes in this cohort are injured subjects who sustain a non-penetrating head injury and are confirmed to have had a concussion according to the protocol reference standard and by their physician.
All subjects enrolled in this cohort are required to have a BrainPulse recording within 3 days of their injury.
Each BrainPulse recording will be accompanied by a symptoms evaluation and medical data collection documented in the case report forms.
Subjects will complete 3 weeks of follow-up visits post injury.
|
JanMedical's BrainPulse measures the brain motion caused by pulsatile blood flow from the cardiac cycle referred to as the BrainPulse signal.
The BrainPulse measures skull acceleration in response to tge brain motion using an array of sensors placed on the head.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Comparison of BrainPulse recordings of concussed subjects with BrainPulse recordings from their matched Controls
Periodo de tiempo: Through study completion, expected to be 8 months
|
Collect BrainPulse data from at least 15 concussed athletes and matched controls to develop and improve algorithms that can aid in the diagnosis of concussion. The specific signal patterns observed from confirmed concussed subjects' BrainPulse recordings will be evaluated against the BrainPulse recordings from the matched control subjects. |
Through study completion, expected to be 8 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Correlate helmet sensor's force of impact measurements with BrainPulse data
Periodo de tiempo: Through study completion, expected to be 8 months
|
Compare the magnitude of force measured by helmet sensors from subconcussive hits with consecutive BrainPulse recordings.
As such, BrainPulse data on these athletes will be compared with helmet sensor data, baseline cognitive testing, and the initial BrainPulse recording.
|
Through study completion, expected to be 8 months
|
|
Compare BrainPulse Data between Injured Athletes, Non-Injured athletes, and Concussed Athletes
Periodo de tiempo: Through study completion, expected 8 months
|
Compare BrainPulse signals in subjects sustaining a non-concussive injury to subjects that have a confirmed diagnosis of concussion.
Also compare BrainPulse signals from injured subjects in Cohort IIa with non-injured subjects in Cohort Ia.
|
Through study completion, expected 8 months
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de noviembre de 2016
Finalización primaria (Actual)
1 de mayo de 2017
Finalización del estudio (Actual)
1 de agosto de 2017
Fechas de registro del estudio
Enviado por primera vez
12 de diciembre de 2016
Primero enviado que cumplió con los criterios de control de calidad
12 de diciembre de 2016
Publicado por primera vez (Estimar)
14 de diciembre de 2016
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
20 de septiembre de 2018
Última actualización enviada que cumplió con los criterios de control de calidad
18 de septiembre de 2018
Última verificación
1 de septiembre de 2018
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- JMC-1602
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Descripción del plan IPD
All study outcome measures will be made available within 6 months of study completion
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .